Vaccine Development

Clinical Trials mRNA Technology Ebola Vaccines Infectious Diseases Epidemiology Immunology COVID-19 Vaccines Clinical Studies Safety Studies Ebola Vaccine

3 ARTICLES

2w ago

Ebola in DR Congo Surges Past 3,000 Cases With 1,405 Deaths

The rare Bundibugyo strain has no licensed vaccine or treatment, prompting rapid trials with response teams facing insecurity, strikes and limited access.

12 ARTICLES

2w ago

Ebola Outbreak in DR Congo Reaches 1,406 Cases as WHO Greenlights Treatment Trials

6 ARTICLES

last mo.

Lancet Review Finds mRNA Vaccines Safe and Highly Effective

8 ARTICLES

last mo.

DRC Bundibugyo Ebola Tops 1,000 Cases as WHO Launches Treatment Trial

75 ARTICLES

2mo ago

Brazil Suspends Butantan Dengue Vaccine After 42 Severe Adverse Reports

3 ARTICLES

2mo ago

CEPI Commits $60 Million to Accelerate Bundibugyo Ebola Vaccines

4 ARTICLES

3mo ago

Rotavirus Spreads Early Across U.S. as Positivity and Wastewater Rise

11 ARTICLES

3mo ago

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

3 ARTICLES

3mo ago

Court Freeze of U.S. Vaccine Panel Puts New Shots, Coverage in Limbo

4 ARTICLES

3mo ago

NHS Opens Spring Covid Booster Bookings for Over-75s and Clinically Vulnerable

13 ARTICLES

3mo ago

Covid Inquiry Hails UK Vaccine Rollout, Demands Overhaul of Compensation

7 ARTICLES

4mo ago

Musk’s X Post on Vaccine Reaction Reignites Scrutiny of Covid Vaccines

3 ARTICLES

5mo ago

CDC Vaccine Advisers Pause Push to End mRNA COVID Shot Recommendations

3 ARTICLES

5mo ago

Brazil’s Single-Dose Dengue Vaccine Shows 5-Year Protection as Rollout to Health Workers Begins

7 ARTICLES

5mo ago

RKI’s First IMPRESS Survey Finds Strong Vaccine Support but Low Seasonal Uptake in Germany

5 ARTICLES

5mo ago

Stanford’s Broad-Acting Nasal Vaccine Shows Mouse Success as Human Trials Are Planned

16 ARTICLES

5mo ago

Stanford’s Nasal Vaccine Shows Broad, Months-Long Protection in Mice as Team Prepares Human Trials

Vaccine Development

Ebola in DR Congo Surges Past 3,000 Cases With 1,405 Deaths

DR Congo Ebola Outbreak Tops 3,000 Cases as Response Strains Mount

Oxford Administers First Human Dose of Bundibugyo Ebola Vaccine

Oxford Launches First Human Trial of Bundibugyo Ebola Vaccine

Ebola Outbreak in DR Congo Reaches 1,406 Cases as WHO Greenlights Treatment Trials

Lancet Review Finds mRNA Vaccines Safe and Highly Effective

DRC Bundibugyo Ebola Tops 1,000 Cases as WHO Launches Treatment Trial

Brazil Suspends Butantan Dengue Vaccine After 42 Severe Adverse Reports

CEPI Commits $60 Million to Accelerate Bundibugyo Ebola Vaccines

Rotavirus Spreads Early Across U.S. as Positivity and Wastewater Rise

Never miss stories about

Vaccine Development

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

Court Freeze of U.S. Vaccine Panel Puts New Shots, Coverage in Limbo

NHS Opens Spring Covid Booster Bookings for Over-75s and Clinically Vulnerable

Covid Inquiry Hails UK Vaccine Rollout, Demands Overhaul of Compensation

Musk’s X Post on Vaccine Reaction Reignites Scrutiny of Covid Vaccines

CDC Vaccine Advisers Pause Push to End mRNA COVID Shot Recommendations

Brazil’s Single-Dose Dengue Vaccine Shows 5-Year Protection as Rollout to Health Workers Begins

RKI’s First IMPRESS Survey Finds Strong Vaccine Support but Low Seasonal Uptake in Germany

Stanford’s Broad-Acting Nasal Vaccine Shows Mouse Success as Human Trials Are Planned

Stanford’s Nasal Vaccine Shows Broad, Months-Long Protection in Mice as Team Prepares Human Trials

Never miss stories about

Vaccine Development